4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-22-053989
Chief Financial Officer gave up 1,111 shares (to pay taxes)
- Chief Financial Officer acquired 3,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Smith Brendan Chief Financial Officer | 2022-10-14 | Option exercise | +3,750 | 3,750 | D | ||
| Smith Brendan Chief Financial Officer | 2022-10-17 | Shares withheld for taxes | −1,111 | $55.76 | $61,949 | 2,639 | D |
| Derivatives | |||||||
| Smith Brendan Chief Financial Officer | 2022-10-14 | Option exercise · Restricted Stock Units | +3,750 | 11,250 | D | ||
Loading xslF345X03/doc4.xml…